Literature DB >> 10364362

Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry.

R Bals1, W Xiao, N Sang, D J Weiner, R L Meegalla, J M Wilson.   

Abstract

The limitations of adeno-associated virus (AAV)-mediated vectors for lung-directed gene transfer were investigated by using differentiated human respiratory epithelium in air-liquid interface cultures. Transduction efficiency was high in undifferentiated cells and was enhanced in well-differentiated cells after basolateral application of the vector or after apical application following disruption of tight junctions or pretreatment of the cultures with glycosidases. These results indicate that transduction of airway epithelia by AAV vectors is limited by entry and reinforce the importance of a physical barrier on the airway surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364362      PMCID: PMC112671     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Immunohistochemical staining for chondroitin sulphate and keratan sulphate. An evaluation of two monoclonal antibodies.

Authors:  S Daugaard; L Strange; T Schiødt
Journal:  Histochemistry       Date:  1991

2.  Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus.

Authors:  J A Wagner; T Reynolds; M L Moran; R B Moss; J J Wine; T R Flotte; P Gardner
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

3.  Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.

Authors:  K Jooss; Y Yang; K J Fisher; J M Wilson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues.

Authors:  S E Hughes; P A Hall
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

5.  Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.

Authors:  R J Pickles; D McCarty; H Matsui; P J Hart; S H Randell; R C Boucher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

Authors:  K Qing; C Mah; J Hansen; S Zhou; V Dwarki; A Srivastava
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

7.  Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein.

Authors:  H Mizukami; N S Young; K E Brown
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

8.  Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.

Authors:  S Teramoto; J S Bartlett; D McCarty; X Xiao; R J Samulski; R C Boucher
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia.

Authors:  G Wang; B L Davidson; P Melchert; V A Slepushkin; H H van Es; M Bodner; D J Jolly; P B McCray
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Adeno-associated virus as a vector for liver-directed gene therapy.

Authors:  W Xiao; S C Berta; M M Lu; A D Moscioni; J Tazelaar; J M Wilson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  31 in total

1.  Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer.

Authors:  R J Pickles; J A Fahrner; J M Petrella; R C Boucher; J M Bergelson
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

3.  Capacity of human beta-defensin expression in gene-transduced and cytokine-induced cells.

Authors:  Chunyi Yin; Hoa N Dang; Hai-Bo Zhang; Farzad Gazor; Daniel Kim; Ole E Sorensen; George T-J Huang
Journal:  Biochem Biophys Res Commun       Date:  2005-11-15       Impact factor: 3.575

4.  A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo.

Authors:  George T-J Huang; Hai-Bo Zhang; Daniel Kim; Lide Liu; Tomas Ganz
Journal:  Hum Gene Ther       Date:  2002-11-20       Impact factor: 5.695

5.  Apical gene transfer into quiescent human and canine polarized intestinal epithelial cells by lentivirus vectors.

Authors:  J Seppen; S C Barry; J H Klinkspoor; L J Katen; S P Lee; J V Garcia; W R Osborne
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08

8.  Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.

Authors:  Wuping Li; Liqun Zhang; Jarrod S Johnson; Wu Zhijian; Joshua C Grieger; Xiao Ping-Jie; Lauren M Drouin; Mavis Agbandje-McKenna; Raymond J Pickles; R Jude Samulski
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

Review 9.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 10.  3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers.

Authors:  Thomas Tyrel Goodman; Chee Ping Ng; Suzie Hwang Pun
Journal:  Bioconjug Chem       Date:  2008-09-13       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.